Your browser doesn't support javascript.
loading
Multicenter benchmarking of short and long read wet lab protocols for clinical viral metagenomics.
Lopez-Labrador, F Xavier; Huber, Michael; Sidorov, Igor A; Brown, Julianne R; Cuypers, Lize; Laenen, Lies; Vanmechelen, Bert; Maes, Piet; Fischer, Nicole; Pichler, Ian; Storey, Nathaniel; Atkinson, Laura; Schmutz, Stefan; Kufner, Verena; van Boheemen, Sander; Mulders, Claudia E; Grundhoff, Adam; Blümke, Patrick; Robitaille, Alexis; Cinek, Ondrej; Hubácková, Klára; Mourik, Kees; Boers, Stefan A; Stauber, Lea; Salmona, Maud; Cappy, Pierre; Ramette, Alban; Franze', Alessandra; LeGoff, Jerome; Claas, Eric C J; Rodriguez, Christophe; de Vries, Jutte J C.
Affiliation
  • Lopez-Labrador FX; Virology Laboratory, Genomics and Health Area, Center for Public Health Research (FISABIO-Public Health), Generalitat Valenciana, Valencia, Spain; Microbiology & Ecology Department, Medical School, University of Valencia, Spain; and CIBERESP, Instituto de Salud Carlos III, Spain.
  • Huber M; Institute of Medical Virology, University of Zurich, Switzerland.
  • Sidorov IA; Clinical Microbiological Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Brown JR; Microbiology, Virology and Infection Prevention & Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
  • Cuypers L; Department of Laboratory Medicine, University Hospitals Leuven, and Laboratory of Clinical Microbiology, KU, Leuven, Belgium.
  • Laenen L; Department of Laboratory Medicine, University Hospitals Leuven, and Laboratory of Clinical Microbiology, KU, Leuven, Belgium.
  • Vanmechelen B; Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Belgium.
  • Maes P; Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Belgium.
  • Fischer N; University Medical Center Hamburg-Eppendorf, UKE Institute for Medical Microbiology, Virology and Hygiene, Germany.
  • Pichler I; Institute of Medical Virology, University of Zurich, Switzerland.
  • Storey N; Microbiology, Virology and Infection Prevention & Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
  • Atkinson L; Microbiology, Virology and Infection Prevention & Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
  • Schmutz S; Institute of Medical Virology, University of Zurich, Switzerland.
  • Kufner V; Institute of Medical Virology, University of Zurich, Switzerland.
  • van Boheemen S; Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Mulders CE; Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Grundhoff A; Leibniz Institute for Virology, Hamburg, Germany.
  • Blümke P; Leibniz Institute for Virology, Hamburg, Germany.
  • Robitaille A; Leibniz Institute for Virology, Hamburg, Germany.
  • Cinek O; Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University, and University Hospital Motol, Prague, Czech Republic.
  • Hubácková K; Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University, and University Hospital Motol, Prague, Czech Republic.
  • Mourik K; Clinical Microbiological Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Boers SA; Clinical Microbiological Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Stauber L; Institute for Infectious Diseases, University of Bern, Switzerland.
  • Salmona M; Virology Department, AP-HP, Hôpital Saint Louis, F-75010 Paris, France.
  • Cappy P; Hospital Henri Mondor, Paris, France.
  • Ramette A; Institute for Infectious Diseases, University of Bern, Switzerland.
  • Franze' A; Virology Laboratory, Genomics and Health Area, Center for Public Health Research (FISABIO-Public Health), Generalitat Valenciana, Valencia, Spain.
  • LeGoff J; Virology Department, AP-HP, Hôpital Saint Louis, F-75010 Paris, France.
  • Claas ECJ; Clinical Microbiological Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Rodriguez C; Hospital Henri Mondor, Paris, France.
  • de Vries JJC; Clinical Microbiological Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: jjcdevries@lumc.nl.
J Clin Virol ; 173: 105695, 2024 08.
Article de En | MEDLINE | ID: mdl-38823290
ABSTRACT
Metagenomics is gradually being implemented for diagnosing infectious diseases. However, in-depth protocol comparisons for viral detection have been limited to individual sets of experimental workflows and laboratories. In this study, we present a benchmark of metagenomics protocols used in clinical diagnostic laboratories initiated by the European Society for Clinical Virology (ESCV) Network on NGS (ENNGS). A mock viral reference panel was designed to mimic low biomass clinical specimens. The panel was used to assess the performance of twelve metagenomic wet lab protocols currently in use in the diagnostic laboratories of participating ENNGS member institutions. Both Illumina and Nanopore, shotgun and targeted capture probe protocols were included. Performance metrics sensitivity, specificity, and quantitative potential were assessed using a central bioinformatics pipeline. Overall, viral pathogens with loads down to 104 copies/ml (corresponding to CT values of 31 in our PCR assays) were detected by all the evaluated metagenomic wet lab protocols. In contrast, lower abundant mixed viruses of CT values of 35 and higher were detected only by a minority of the protocols. Considering the reference panel as the gold standard, optimal thresholds to define a positive result were determined per protocol, based on the horizontal genome coverage. Implementing these thresholds, sensitivity and specificity of the protocols ranged from 67 to 100 % and 87 to 100 %, respectively. A variety of metagenomic protocols are currently in use in clinical diagnostic laboratories. Detection of low abundant viral pathogens and mixed infections remains a challenge, implying the need for standardization of metagenomic analysis for use in clinical settings.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Virus / Sensibilité et spécificité / Référenciation / Métagénomique Limites: Humans Langue: En Journal: J Clin Virol Sujet du journal: VIROLOGIA Année: 2024 Type de document: Article Pays d'affiliation: Espagne Pays de publication: Pays-Bas

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Virus / Sensibilité et spécificité / Référenciation / Métagénomique Limites: Humans Langue: En Journal: J Clin Virol Sujet du journal: VIROLOGIA Année: 2024 Type de document: Article Pays d'affiliation: Espagne Pays de publication: Pays-Bas